Health ❯ Pharmaceuticals

Drug Research

Clinical Trials Clinical Testing Protein Functions New Treatments Bioactive Compounds Molecular Therapies Therapeutic Drug Candidate Clinical Studies Biotechnology Inflammatory Disorders Immunology RNA-Based Treatments AI-Driven Drug Discovery Drug Pipeline

Lilly Sues Six U.S. Firms Over Black‑Market Sales of Experimental Drug Retatrutide

Lilly says the lawsuits are intended to force platforms and regulators to cut off an unsafe black‑market supply chain for its unapproved drug.

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

Biogen Licenses Vanqua’s Preclinical C5aR1 Drug in Deal Worth Up to $1.06 Billion

Emory Revamps Chan–Evans–Lam Reaction to Expand Access to Vinylic Ethers

Peer-Reviewed OU Study Maps Amylin Receptors, Offering Tools for Next‑Gen Obesity Drugs